OncoHost, a global leader in host response profiling for improved personalized cancer therapy, announced today that Professor Yuval Shaked, co-founder and Chief Scientific Advisor at OncoHost, and Professor of Cell Biology and Cancer Science at the Technion – Israel Institute of Technology, will deliver a presentation titled A Proteomics-Based Platform for Predicting Response to Immunotherapy and Personalizing Treatment Plans at the MAP 2020 Virtual Congress - ESMO this Friday, October 9th at 17:20 PM CEST.
Info:
prnewswire.com/il/news-releases/oncohost-to-present-data-on-predicting-host-response-to-immunotherapy-at-the-map-2020-virtual-congress---esmo-301145545.html
No comments:
Post a Comment